Dr. Taylor Discusses the Management of Endometrial Cancer

Alexandra Taylor, MD
Published: Thursday, Jan 18, 2018



Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the management of endometrial cancer.

One of the challenges in managing endometrial cancer is the high rate of comorbidities within the population, Taylor says. More than 80% of patients with endometrial cancer are obese, and there is a high instance of diabetes, cardiovascular disease, arthritis, and poor renal function. Taylor says that individualized treatment would be beneficial to these patients, considering the high rate of comorbidities and importance of quality-of-life. 

There is a lack of quality-of-life and patient reported outcomes, Taylor adds. Currently, the survival benefits for this population is modest, but the treatment regimen can have a huge impact on a woman’s quality of life. Clinicians needs to work with patients to develop strategies that optimize their quality of life alongside treatment, Taylor says.
 
SELECTED
LANGUAGE


Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the management of endometrial cancer.

One of the challenges in managing endometrial cancer is the high rate of comorbidities within the population, Taylor says. More than 80% of patients with endometrial cancer are obese, and there is a high instance of diabetes, cardiovascular disease, arthritis, and poor renal function. Taylor says that individualized treatment would be beneficial to these patients, considering the high rate of comorbidities and importance of quality-of-life. 

There is a lack of quality-of-life and patient reported outcomes, Taylor adds. Currently, the survival benefits for this population is modest, but the treatment regimen can have a huge impact on a woman’s quality of life. Clinicians needs to work with patients to develop strategies that optimize their quality of life alongside treatment, Taylor says.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Consultations® in Ovarian Cancer: Differentiating Among Clinical Trial Designs to Match PARP to PatientOct 31, 20191.5
Cancer Summaries and Commentaries™: Update from Munich: Advances in the Treatment of Lung Cancer, Genitourinary Malignancies, and Gynecologic MalignanciesDec 30, 20192.25
Publication Bottom Border
Border Publication
x